Rochester,NY 8/28/2009 1:33:03 AM
Bristol Myers Squibb Co.,BMY-Bristol-Myers Squibb Co.'s Subsidiary accomplishes Initial Tender Offer For Medarex, Inc
Bristol Myers Squibb Co
Bristol-Myers Squibb Co. declared that the initial tender offer, through its wholly owned subsidiary, Puma Acquisition Corporation, for all outstanding shares of common stock of Medarex, Inc. expired at midnight (New York City time) on August 26, 2009, and was not extended.
The depositary for the tender offer has advised Bristol-Myers Squibb that, as of the expiration of the initial tender offer, shareholders of Medarex tendered approximately 119,012,034 shares of Medarex common stock, representing approximately 87.7% of the Medarex shares outstanding.
About Stock EinsteinStockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
